Jonathan Yong
Stock Analyst at UBS
(2.61)
# 2,203
Out of 4,918 analysts
105
Total ratings
60.71%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $13.58 | -19.00% | 8 | Jul 15, 2025 | |
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $3.21 | +118.07% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $2.78 | +43.88% | 3 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $21.27 | +17.54% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.64 | +157.73% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $6.52 | +84.05% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.53 | +76.60% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.09 | +98.62% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $62.55 | -77.62% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $67.98 | +41.22% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $12.57 | +154.57% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $17.85 | +488.24% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $108.53 | -26.29% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $261.50 | -11.66% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $98.51 | +2.53% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $6.94 | +289.05% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $156.00 | -35.90% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $698.80 | -35.60% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.74 | +220.86% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.01 | +898.57% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $13.07 | +30.07% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $155.13 | +125.62% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $21.12 | +349.81% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.57 | +52.60% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $18.86 | +117.39% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $6.57 | +158.75% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.44 | +248.36% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $77.83 | +9.21% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $170.85 | -14.54% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $25.91 | +309.11% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $162.98 | -3.67% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $262.23 | +40.33% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $247.26 | +156.81% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $62.47 | +87.29% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $11.98 | +150.42% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $356.97 | -16.52% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $158.09 | -39.91% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $237.77 | +108.18% | 1 | Oct 15, 2021 |
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $13.58
Upside: -19.00%
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $3.21
Upside: +118.07%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $2.78
Upside: +43.88%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $21.27
Upside: +17.54%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.64
Upside: +157.73%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $6.52
Upside: +84.05%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.53
Upside: +76.60%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.09
Upside: +98.62%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $62.55
Upside: -77.62%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $67.98
Upside: +41.22%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $12.57
Upside: +154.57%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $17.85
Upside: +488.24%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $108.53
Upside: -26.29%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $261.50
Upside: -11.66%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $98.51
Upside: +2.53%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $6.94
Upside: +289.05%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $156.00
Upside: -35.90%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $698.80
Upside: -35.60%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.74
Upside: +220.86%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.01
Upside: +898.57%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $13.07
Upside: +30.07%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $155.13
Upside: +125.62%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $21.12
Upside: +349.81%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.57
Upside: +52.60%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $18.86
Upside: +117.39%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $6.57
Upside: +158.75%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.44
Upside: +248.36%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $77.83
Upside: +9.21%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $170.85
Upside: -14.54%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $25.91
Upside: +309.11%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $162.98
Upside: -3.67%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $262.23
Upside: +40.33%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $247.26
Upside: +156.81%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $62.47
Upside: +87.29%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $11.98
Upside: +150.42%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $356.97
Upside: -16.52%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $158.09
Upside: -39.91%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $237.77
Upside: +108.18%